Jianfeng Cui

1.0k total citations
46 papers, 736 citations indexed

About

Jianfeng Cui is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Jianfeng Cui has authored 46 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 15 papers in Surgery and 14 papers in Oncology. Recurrent topics in Jianfeng Cui's work include Bladder and Urothelial Cancer Treatments (7 papers), Cancer, Lipids, and Metabolism (5 papers) and Renal cell carcinoma treatment (4 papers). Jianfeng Cui is often cited by papers focused on Bladder and Urothelial Cancer Treatments (7 papers), Cancer, Lipids, and Metabolism (5 papers) and Renal cell carcinoma treatment (4 papers). Jianfeng Cui collaborates with scholars based in China, Russia and Canada. Jianfeng Cui's co-authors include Benkang Shi, Yangyang Xia, Yaofeng Zhu, Yongxin Zou, Pengxiang Chen, Shuna Sun, Shouzhen Chen, Lipeng Chen, Xuewen Jiang and Wenfu Wang and has published in prestigious journals such as Oncogene, Scientific Reports and Biochemical Pharmacology.

In The Last Decade

Jianfeng Cui

46 papers receiving 730 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianfeng Cui China 16 331 173 166 149 120 46 736
Qi Shen China 17 375 1.1× 188 1.1× 101 0.6× 108 0.7× 139 1.2× 52 859
Zhiwen Chen China 20 562 1.7× 236 1.4× 261 1.6× 142 1.0× 174 1.4× 70 1.0k
Fangfang Duan China 15 317 1.0× 182 1.1× 164 1.0× 128 0.9× 73 0.6× 53 682
Ľ Danihel Slovakia 13 432 1.3× 247 1.4× 253 1.5× 111 0.7× 82 0.7× 67 952
Binghui Li China 19 596 1.8× 131 0.8× 445 2.7× 99 0.7× 80 0.7× 44 1.0k
Hyojin Kim South Korea 14 242 0.7× 327 1.9× 144 0.9× 308 2.1× 58 0.5× 59 958
Suk‐young Lee South Korea 16 395 1.2× 216 1.2× 148 0.9× 111 0.7× 46 0.4× 43 719

Countries citing papers authored by Jianfeng Cui

Since Specialization
Citations

This map shows the geographic impact of Jianfeng Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianfeng Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianfeng Cui more than expected).

Fields of papers citing papers by Jianfeng Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianfeng Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianfeng Cui. The network helps show where Jianfeng Cui may publish in the future.

Co-authorship network of co-authors of Jianfeng Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Jianfeng Cui. A scholar is included among the top collaborators of Jianfeng Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianfeng Cui. Jianfeng Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Jinyan, et al.. (2023). Scientific and simulation study of the manufacturing technology of the ancient Chinese rare Hare’s Fur glazed bowl. Journal of the European Ceramic Society. 44(3). 1856–1863. 5 indexed citations
2.
Fu, Qiang, Keqin Zhang, Wenfu Wang, et al.. (2023). Nomograms Combining PHI and PI-RADS in Detecting Prostate Cancer: A Multicenter Prospective Study. Journal of Clinical Medicine. 12(1). 339–339. 8 indexed citations
3.
Wang, Shuai, Xiaohui Yang, Linchen Lv, et al.. (2023). Gut microbiome in men with chronic prostatitis/chronic pelvic pain syndrome: profiling and its predictive significance. World Journal of Urology. 41(11). 3019–3026. 11 indexed citations
5.
Wang, Jian, Jianfeng Cui, Sifeng Qu, et al.. (2022). Arterioureteral fistula after radical cystectomy and ureterocutaneostomy: two case reports and a systematic literature review. BMC Urology. 22(1). 117–117. 1 indexed citations
6.
Chen, Lipeng, Linchen Lv, Lekai Zhang, et al.. (2021). Metformin ameliorates bladder dysfunction in a rat model of partial bladder outlet obstruction. American Journal of Physiology-Renal Physiology. 320(5). F838–F858. 15 indexed citations
7.
Liu, Lei, Jianfeng Cui, Yajing Zhao, et al.. (2021). KDM6A-ARHGDIB axis blocks metastasis of bladder cancer by inhibiting Rac1. Molecular Cancer. 20(1). 77–77. 62 indexed citations
8.
Jiang, Xuewen, Yangyang Xia, Hui Meng, et al.. (2021). Identification of a Nuclear Mitochondrial-Related Multi-Genes Signature to Predict the Prognosis of Bladder Cancer. Frontiers in Oncology. 11. 746029–746029. 10 indexed citations
9.
Liu, Zhengfang, Hu Guo, Yaofeng Zhu, et al.. (2020). TP53 alterations of hormone-naïve prostate cancer in the Chinese population. Prostate Cancer and Prostatic Diseases. 24(2). 482–491. 29 indexed citations
10.
Wu, Zonglong, Qinggang Liu, Yaxiao Liu, et al.. (2020). Profiles of Immune Infiltration in Bladder Cancer and its Clinical Significance: an Integrative Genomic Analysis. International Journal of Medical Sciences. 17(6). 762–772. 17 indexed citations
11.
Meng, Hui, et al.. (2020). Genomic Analysis Reveals Novel Specific Metastatic Mutations in Chinese Clear Cell Renal Cell Carcinoma. BioMed Research International. 2020(1). 2495157–2495157. 12 indexed citations
12.
Wang, Yong, Lipeng Chen, Yangyang Xia, et al.. (2020). CUL4B promotes aggressive phenotypes of renal cell carcinoma via upregulating c-Met expression. The International Journal of Biochemistry & Cell Biology. 130. 105887–105887. 3 indexed citations
13.
Liu, Xiaochen, Jianfeng Cui, Li Gong, et al.. (2020). The CUL4B-miR-372/373-PIK3CA-AKT axis regulates metastasis in bladder cancer. Oncogene. 39(17). 3588–3603. 27 indexed citations
14.
Wang, Rui, Yan Li, Shouzhen Chen, et al.. (2018). CCL17‐CCR4 axis promotes metastasis via ERK/MMP13 pathway in bladder cancer. Journal of Cellular Biochemistry. 120(2). 1979–1989. 21 indexed citations
15.
Cui, Jianfeng, Hu Guo, Yaofeng Zhu, et al.. (2017). Pelvic Floor Reconstruction After Radical Prostatectomy: A Systematic Review and Meta-analysis of Different Surgical Techniques. Scientific Reports. 7(1). 2737–2737. 8 indexed citations
17.
Chen, Shouzhen, Yaofeng Zhu, Jianfeng Cui, et al.. (2017). The role of c-Met in prognosis and clinicopathology of renal cell carcinoma: Results from a single-centre study and systematic review. Urologic Oncology Seminars and Original Investigations. 35(8). 532.e15–532.e23. 8 indexed citations
18.
Cui, Jianfeng, Shiyu Wang, Ning Zhang, et al.. (2017). Preoperative prognostic nutritional index and nomogram predicting recurrence-free survival in patients with primary non-muscle-invasive bladder cancer without carcinoma in situ. OncoTargets and Therapy. Volume 10. 5541–5550. 13 indexed citations
19.
Wang, Xiangyu, Yang Wang, Hui Meng, et al.. (2016). Ectopic Cushing’s syndrome due to retroperitoneal ACTH-producing paragangliomas. Canadian Urological Association Journal. 10(9-10). 320–320. 3 indexed citations
20.
Chen, Fan, et al.. (2015). Clinical characteristics and pathology of thyroid-like follicular carcinoma of the kidney: Report of 3 cases and a literature review. Molecular and Clinical Oncology. 4(2). 143–150. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026